Top Markets
#1 Official Trump Official Trump +42.55%
#2 Melania Meme Melania Meme +23.83%
#3 EXOD EXOD +18.93%
#4 Movement Movement +17.86%
#5 Mubarak Mubarak +17.15%
#6 Wrapped STX (Velar) Wrapped STX (Velar) +15.62%
#7 POL (ex-MATIC) POL (ex-MATIC) +15.51%
#8 Wrapped POL Wrapped POL +15.32%
#9 Unit Pump Unit Pump +10.71%
#10 Pump.fun Pump.fun +10.71%
Coin of the day
Official Trump Official Trump
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
OS Therapies Incorporated OS Therapies Incorporated

OS Therapies Incorporated

OSTX
Clasificación en acciones #23564
OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses... OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. Its pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate (ADC) silicone dioxide linker technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. OS Therapies Incorporated was incorporated in 2018 and is based in Grasonville, Maryland.
Precio por acción
$1.58
Última sincronización: 2026-08-21
Capitalización bursátil
$71.95M
Cambio (1 día)
0.64%
Cambio (1 año)
-36.29%
País
US
Comercio OS Therapies Incorporated (OSTX)

Categoría

Healthcare
Ganancias de OS Therapies Incorporated (OSTX)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di OS Therapies Incorporated, gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de OS Therapies Incorporated desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH